Artwork

Content provided by DKBmed. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by DKBmed or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Player FM - Aplicație Podcast
Treceți offline cu aplicația Player FM !

Newer Options for Treatment-Experienced Patients Podcast

33:52
 
Distribuie
 

Manage episode 343699555 series 2065653
Content provided by DKBmed. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by DKBmed or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

Treatment-experienced patients with RAMs — resistance-associated mutations — remain a difficult management challenge. Every case of HIV drug resistance requires a therapeutic regimen individualized for each patient’s ART history. How will new and in-development agents affect the equation?

Which drug combinations are right? Where does the balance between side effects and adherence lie?

These are some of the questions Dr. Brian Wood from the Division of Allergy and Infectious Diseases at the University of Washington in Seattle addresses in this eHIV Review podcast.


Take our post-test to claim CME credits.

To read a companion newsletter click here.



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

214 episoade

Artwork
iconDistribuie
 
Manage episode 343699555 series 2065653
Content provided by DKBmed. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by DKBmed or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

Treatment-experienced patients with RAMs — resistance-associated mutations — remain a difficult management challenge. Every case of HIV drug resistance requires a therapeutic regimen individualized for each patient’s ART history. How will new and in-development agents affect the equation?

Which drug combinations are right? Where does the balance between side effects and adherence lie?

These are some of the questions Dr. Brian Wood from the Division of Allergy and Infectious Diseases at the University of Washington in Seattle addresses in this eHIV Review podcast.


Take our post-test to claim CME credits.

To read a companion newsletter click here.



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

214 episoade

Усі епізоди

×
 
Loading …

Bun venit la Player FM!

Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.

 

Ghid rapid de referință